This is a preview of subscription content, log in via an institution to check access.
Reference
Rowland MR, et al. Cost-utility comparison of neoadjuvant chemotherapy versus primary debulking surgery for treatment of advanced stage ovarian cancer in patients >/= 65 years old. American Journal of Obstetrics and Gynecology : 31 Jan 2015. Available from: URL: http://doi.org/10.1016/j.ajog.2015.01.053
Rights and permissions
About this article
Cite this article
NACT preferred option in elderly women with AEOC. PharmacoEcon Outcomes News 722, 19 (2015). https://doi.org/10.1007/s40274-015-1925-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-1925-0